Transfusion hemosiderosis
From Wikipedia, the free encyclopedia
Transfusion hemosiderosis Classification and external resources |
|
ICD-9 | 999.8 |
---|
Transfusional hemosiderosis is the accumulation of iron in the liver and/or heart but also endocrine organs, in patients who receive frequent blood transfusions (such as those with thalassemia, sickle cell disease, aplastic anemia or myelodysplastic syndrome).
Contents |
[edit] Treatment
Treatment is by iron chelating agents: deferoxamine,[1] deferiprone or deferasirox. If iron overload has caused end-organ damage, this is generally irreversible and may require transplantation.
[edit] Notable patients
Ted DeVita, the "bubble boy", died of transfusional iron overload from too many blood transfusions.
[edit] See also
[edit] References
- ^ Cappellini MD (June 2007). "Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion". Ther Clin Risk Manag 3 (2): 291–9. PMID 18360637.